(SAF) Safran - Overview
Stock: Propulsion, Landing Gear, Avionics, Seats, Cabin
Dividends
| Dividend Yield | 1.12% |
| Yield on Cost 5y | 2.69% |
| Yield CAGR 5y | 61.15% |
| Payout Consistency | 88.3% |
| Payout Ratio | 28.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 21.3% |
| Relative Tail Risk | -1.86% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.85 |
| Alpha | 20.84 |
| Character TTM | |
|---|---|
| Beta | 0.190 |
| Beta Downside | 0.422 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.09% |
| CAGR/Max DD | 1.46 |
Description: SAF Safran January 27, 2026
Safran SA (ticker SAF) is a French aerospace and defense group that operates globally across three main divisions: Aerospace Propulsion, Aircraft Equipment & Defense & Aerosystems, and Aircraft Interiors. The company designs, manufactures and services propulsion systems, landing-gear and avionics, as well as cabin-fit equipment such as seats, galleys and in-flight entertainment.
In FY 2023 Safran reported €22.2 billion in revenue, an operating margin of 8.5 % and a consolidated order backlog of roughly €33 billion, indicating a multi-year demand cushion. R&D spending remained at about 5 % of sales, supporting its roadmap for hybrid-electric propulsion and next-generation IFEC solutions. The commercial aerospace propulsion market is projected to grow at a 4 % CAGR through 2029, while global defense budgets have risen ~3 % YoY, both of which are key tailwinds for Safran’s segments.
Given the company’s diversified product mix and strong backlog, analysts often focus on the pace of commercial jet deliveries, defense procurement cycles, and the rollout of new cabin-technology standards as primary catalysts for earnings upside.
For a deeper, data-driven dive into Safran’s valuation metrics and scenario analysis, you may find the ValueRay platform useful.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 5.96b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 5.29 > 1.0 |
| NWC/Revenue: -4.54% < 20% (prev -9.00%; Δ 4.47% < -1%) |
| CFO/TA 0.17 > 3% & CFO 9.56b > Net Income 5.96b |
| Net Debt (-1.59b) to EBITDA (7.98b): -0.20 < 3 |
| Current Ratio: 0.93 > 1.5 & < 3 |
| Outstanding Shares: last quarter (417.9m) vs 12m ago -3.82% < -2% |
| Gross Margin: 40.83% > 18% (prev 0.22%; Δ 4060 % > 0.5%) |
| Asset Turnover: 105.6% > 50% (prev 64.69%; Δ 40.92% > 0%) |
| Interest Coverage Ratio: 30.18 > 6 (EBITDA TTM 7.98b / Interest Expense TTM 168.0m) |
Altman Z'' 0.91
| A: -0.04 (Total Current Assets 34.97b - Total Current Liabilities 37.47b) / Total Assets 56.09b |
| B: 0.09 (Retained Earnings 5.04b / Total Assets 56.09b) |
| C: 0.10 (EBIT TTM 5.07b / Avg Total Assets 52.18b) |
| D: 0.24 (Book Value of Equity 10.31b / Total Liabilities 42.31b) |
| Altman-Z'' Score: 0.91 = BB |
Beneish M -3.30
| DSRI: 0.75 (Receivables 14.36b/10.88b, Revenue 55.10b/31.22b) |
| GMI: 0.54 (GM 40.83% / 22.19%) |
| AQI: 0.77 (AQ_t 0.28 / AQ_t-1 0.36) |
| SGI: 1.77 (Revenue 55.10b / 31.22b) |
| TATA: -0.06 (NI 5.96b - CFO 9.56b) / TA 56.09b) |
| Beneish M-Score: -3.30 (Cap -4..+1) = AA |
What is the price of SAF shares?
Over the past week, the price has changed by +2.33%, over one month by -1.50%, over three months by +1.72% and over the past year by +29.24%.
Is SAF a buy, sell or hold?
What are the forecasts/targets for the SAF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 338.9 | 10% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 406.4 | 31.9% |
SAF Fundamental Data Overview February 02, 2026
P/E Trailing = 29.1384
P/E Forward = 27.933
P/S = 4.271
P/B = 9.4063
P/EG = 1.7084
Revenue TTM = 55.10b EUR
EBIT TTM = 5.07b EUR
EBITDA TTM = 7.98b EUR
Long Term Debt = 2.11b EUR (from longTermDebt, last quarter)
Short Term Debt = 2.43b EUR (from shortTermDebt, last quarter)
Debt = 5.12b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.59b EUR (from netDebt column, last quarter)
Enterprise Value = 123.59b EUR (125.47b + Debt 5.12b - CCE 6.99b)
Interest Coverage Ratio = 30.18 (Ebit TTM 5.07b / Interest Expense TTM 168.0m)
EV/FCF = 16.73x (Enterprise Value 123.59b / FCF TTM 7.39b)
FCF Yield = 5.98% (FCF TTM 7.39b / Enterprise Value 123.59b)
FCF Margin = 13.40% (FCF TTM 7.39b / Revenue TTM 55.10b)
Net Margin = 10.81% (Net Income TTM 5.96b / Revenue TTM 55.10b)
Gross Margin = 40.83% ((Revenue TTM 55.10b - Cost of Revenue TTM 32.61b) / Revenue TTM)
Gross Margin QoQ = 51.08% (prev 45.93%)
Tobins Q-Ratio = 2.20 (Enterprise Value 123.59b / Total Assets 56.09b)
Interest Expense / Debt = 1.09% (Interest Expense 56.0m / Debt 5.12b)
Taxrate = 28.71% (2.06b / 7.17b)
NOPAT = 3.61b (EBIT 5.07b * (1 - 28.71%))
Current Ratio = 0.93 (Total Current Assets 34.97b / Total Current Liabilities 37.47b)
Debt / Equity = 0.39 (Debt 5.12b / totalStockholderEquity, last quarter 13.22b)
Debt / EBITDA = -0.20 (Net Debt -1.59b / EBITDA 7.98b)
Debt / FCF = -0.22 (Net Debt -1.59b / FCF TTM 7.39b)
Total Stockholder Equity = 11.68b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.42% (Net Income 5.96b / Total Assets 56.09b)
RoE = 51.04% (Net Income TTM 5.96b / Total Stockholder Equity 11.68b)
RoCE = 36.78% (EBIT 5.07b / Capital Employed (Equity 11.68b + L.T.Debt 2.11b))
RoIC = 30.03% (NOPAT 3.61b / Invested Capital 12.04b)
WACC = 6.38% (E(125.47b)/V(130.59b) * Re(6.61%) + D(5.12b)/V(130.59b) * Rd(1.09%) * (1-Tc(0.29)))
Discount Rate = 6.61% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.15%
[DCF Debug] Terminal Value 86.73% ; FCFF base≈5.95b ; Y1≈7.34b ; Y5≈12.51b
Fair Price DCF = 754.9 (EV 312.83b - Net Debt -1.59b = Equity 314.42b / Shares 416.5m; r=6.38% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 29.36 | EPS CAGR: 5.02% | SUE: 0.0 | # QB: 0
Revenue Correlation: 56.11 | Revenue CAGR: 24.36% | SUE: 0.10 | # QB: 0
EPS next Year (2026-12-31): EPS=10.40 | Chg30d=-0.195 | Revisions Net=-4 | Growth EPS=+25.5% | Growth Revenue=+12.6%